Tci Wealth Advisors, Inc. Neogenomics Inc Transaction History

Tci Wealth Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$9.09 - $19.45 $2,290 - $4,901	-252 Reduced 37.44%	421 $7,000
Q4 2022 Feb 06, 2023	BUY	$6.45 - $12.07 $4,340 - $8,123	673 New	673 $6,000
Q2 2022 Jul 19, 2022	BUY	$7.06 - $13.97 $2,774 - $5,490	393 New	393 $3,000
Q1 2022 Apr 29, 2022	SELL	$12.15 - $35.28 $1,518 - $4,410	-125 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$30.49 - $48.49 $7,713 - $12,267	-253 Reduced 66.93%	125 $4,000
Q3 2021 Oct 29, 2021	BUY	$41.66 - $52.52 $6,957 - $8,770	167 Added 79.15%	378 $18,000
Q2 2021 Aug 02, 2021	SELL	$36.62 - $51.69 $2,307 - $3,256	-63 Reduced 22.99%	211 $10,000
Q1 2021 Apr 29, 2021	BUY	$41.56 - $59.88 $5,070 - $7,305	122 Added 80.26%	274 $13,000
Q1 2020 Apr 14, 2020	BUY	$20.5 - $34.53 $1,681 - $2,831	82 Added 117.14%	152 $4,000
Q4 2019 Jan 27, 2020	SELL	$18.96 - $29.84 $853 - $1,342	-45 Reduced 39.13%	70 $2,000
Q3 2019 Oct 17, 2019	BUY	$19.12 - $26.24 $860 - $1,180	45 Added 64.29%	115 $2,000
Q2 2019 Jul 23, 2019	BUY	$19.57 - $24.1 $332 - $409	17 Added 32.08%	70 $2,000
Q1 2019 Apr 11, 2019	BUY	$12.14 - $20.46 $643 - $1,084	53 New	53 $1,000

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.